Published in Stem Cell Rev on December 01, 2009
Use of mesenchymal stem cells for therapy of cardiac disease. Circ Res (2015) 1.57
Pericyte TIMP3 and ADAMTS1 modulate vascular stability after kidney injury. J Am Soc Nephrol (2012) 1.48
Human embryonic stem cell-derived vascular progenitor cells capable of endothelial and smooth muscle cell function. Exp Hematol (2010) 1.33
Perivascular human endometrial mesenchymal stem cells express pathways relevant to self-renewal, lineage specification, and functional phenotype. Biol Reprod (2012) 1.24
Pivotal role of pericytes in kidney fibrosis. Clin Exp Pharmacol Physiol (2011) 1.05
The Nell-1 growth factor stimulates bone formation by purified human perivascular cells. Tissue Eng Part A (2011) 1.02
Role of pericytes in skeletal muscle regeneration and fat accumulation. Stem Cells Dev (2013) 1.01
The role of pericyte detachment in vascular rarefaction. J Vasc Res (2014) 0.98
Pericytes at the intersection between tissue regeneration and pathology. Clin Sci (Lond) (2015) 0.92
Mesenchymal stem cells and cardiovascular disease: a bench to bedside roadmap. Stem Cells Int (2012) 0.92
Improved functional activity of bone marrow derived circulating progenitor cells after intra coronary freshly isolated bone marrow cells transplantation in patients with ischemic heart disease. Stem Cell Rev (2011) 0.89
Pericytes in the eye. Pflugers Arch (2013) 0.87
The role of pericytes in neurovascular unit remodeling in brain disorders. Int J Mol Sci (2014) 0.84
Impaired endothelium-mesenchymal stem cells cross-talk in systemic sclerosis: a link between vascular and fibrotic features. Arthritis Res Ther (2014) 0.83
Impaired Cav-1 expression in SSc mesenchymal cells upregulates VEGF signaling: a link between vascular involvement and fibrosis. Fibrogenesis Tissue Repair (2014) 0.79
Comparison of Effects of Mechanical Stretching on Osteogenic Potential of ASCs and BMSCs. Bone Res (2013) 0.78
Amniotic Mesenchymal Stem Cells Can Enhance Angiogenic Capacity via MMPs In Vitro and In Vivo. Biomed Res Int (2015) 0.76
Analyzing Structure and Function of Vascularization in Engineered Bone Tissue by Video-Rate Intravital Microscopy and 3D Image Processing. Tissue Eng Part C Methods (2015) 0.75
Microscale technologies for tissue engineering and biology. Proc Natl Acad Sci U S A (2006) 6.66
Regeneration and orthotopic transplantation of a bioartificial lung. Nat Med (2010) 5.59
Regeneration and experimental orthotopic transplantation of a bioengineered kidney. Nat Med (2013) 5.36
FSH directly regulates bone mass. Cell (2006) 4.64
Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment. Nature (2009) 4.14
STAT3 deletion during hematopoiesis causes Crohn's disease-like pathogenesis and lethality: a critical role of STAT3 in innate immunity. Proc Natl Acad Sci U S A (2003) 3.46
A biodegradable and biocompatible gecko-inspired tissue adhesive. Proc Natl Acad Sci U S A (2008) 2.58
Endothelialized microvasculature based on a biodegradable elastomer. Tissue Eng (2005) 2.23
Progress in tissue engineering. Sci Am (2009) 2.08
Endothelialized networks with a vascular geometry in microfabricated poly(dimethyl siloxane). Biomed Microdevices (2004) 1.97
Estrogen protects bone by inducing Fas ligand in osteoblasts to regulate osteoclast survival. EMBO J (2008) 1.96
Biocompatibility analysis of poly(glycerol sebacate) as a nerve guide material. Biomaterials (2005) 1.93
Enhanced in vivo function of bioartificial lungs in rats. Ann Thorac Surg (2011) 1.75
Discovery of alogliptin: a potent, selective, bioavailable, and efficacious inhibitor of dipeptidyl peptidase IV. J Med Chem (2007) 1.73
Bone mass is inversely proportional to Dkk1 levels in mice. Bone (2007) 1.71
Tissue-engineered small intestine improves recovery after massive small bowel resection. Ann Surg (2004) 1.64
Three-Dimensional Microfluidic Tissue-Engineering Scaffolds Using a Flexible Biodegradable Polymer. Adv Mater (2005) 1.49
Microfabrication of three-dimensional engineered scaffolds. Tissue Eng (2007) 1.48
Engineered vascularized bone grafts. Proc Natl Acad Sci U S A (2010) 1.47
Tissue-engineered hybrid tooth and bone. Tissue Eng (2005) 1.46
Selective labeling of proteins by using protein farnesyltransferase. Chembiochem (2007) 1.43
Bioabsorbable anterior cervical plate fixation for single-level degenerative disorders: early clinical and radiographic experience. Spine J (2011) 1.40
Hepatic tissue engineering. Transpl Immunol (2004) 1.36
In vivo bone tissue engineering using mesenchymal stem cells on a novel electrospun nanofibrous scaffold. Tissue Eng (2004) 1.34
A study of the role of nell-1 gene modified goat bone marrow stromal cells in promoting new bone formation. Mol Ther (2007) 1.31
Mandibular repair in rats with premineralized silk scaffolds and BMP-2-modified bMSCs. Biomaterials (2009) 1.29
Side population in oral squamous cell carcinoma possesses tumor stem cell phenotypes. Cancer Lett (2009) 1.27
The tissue-engineered auricle: past, present, and future. Tissue Eng Part B Rev (2011) 1.20
Hydrogel-beta-TCP scaffolds and stem cells for tissue engineering bone. Bone (2005) 1.20
Calcium regulates the PI3K-Akt pathway in stretched osteoblasts. FEBS Lett (2003) 1.19
Identification of a potential ovarian cancer stem cell gene expression profile from advanced stage papillary serous ovarian cancer. PLoS One (2012) 1.18
Hepatic tissue engineering: from transplantation to customized cell-based liver directed therapies from the laboratory. J Cell Mol Med (2007) 1.18
Local delivery of basic fibroblast growth factor increases both angiogenesis and engraftment of hepatocytes in tissue-engineered polymer devices. Transplantation (2002) 1.17
Tissue engineering auricular reconstruction: in vitro and in vivo studies. Biomaterials (2004) 1.17
Synthesis of the Globo H Hexasaccharide Using the Programmable Reactivity-Based One-Pot Strategy This research was supported by the National Institutes of Health. F.B. thanks the Deutsche Forschungsgemeinschaft for a fellowship. Angew Chem Int Ed Engl (2001) 1.17
Tissue-engineered large intestine resembles native colon with appropriate in vitro physiology and architecture. Ann Surg (2003) 1.17
Percutaneous transvenous cellular cardiomyoplasty. A novel nonsurgical approach for myocardial cell transplantation. J Am Coll Cardiol (2003) 1.15
Highly purified müllerian inhibiting substance inhibits human ovarian cancer in vivo. Clin Cancer Res (2002) 1.15
Repair of critical-sized rat calvarial defects using genetically engineered bone marrow-derived mesenchymal stem cells overexpressing hypoxia-inducible factor-1α. Stem Cells (2011) 1.14
Degradation behavior of poly(glycerol sebacate). J Biomed Mater Res A (2009) 1.14
Incorporation of excess gadolinium into human bone from medical contrast agents. Metallomics (2009) 1.13
Lung assist device technology with physiologic blood flow developed on a tissue engineered scaffold platform. Lab Chip (2010) 1.13
Reconstruction of mandibular defects with autologous tissue-engineered bone. J Oral Maxillofac Surg (2004) 1.13
Application of modified retromandibular approach indirectly from the anterior edge of the parotid gland in the surgical treatment of condylar fracture. J Oral Maxillofac Surg (2009) 1.12
The NF-kappa B inhibitor, celastrol, could enhance the anti-cancer effect of gambogic acid on oral squamous cell carcinoma. BMC Cancer (2009) 1.12
Synergistic effects of Nell-1 and BMP-2 on the osteogenic differentiation of myoblasts. J Bone Miner Res (2007) 1.11
Identification of genes associated with cisplatin resistance in human oral squamous cell carcinoma cell line. BMC Cancer (2006) 1.11
VEGF enhancement of osteoclast survival and bone resorption involves VEGF receptor-2 signaling and beta3-integrin. Matrix Biol (2008) 1.11
Comparative study of clinical manifestation, plain-film radiography, and computed tomographic scan in arteriovenous malformations of the jaws. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2002) 1.10
Orbital floor reconstruction: a retrospective study of 21 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2008) 1.09
Tissue-engineered esophagus: experimental substitution by onlay patch or interposition. J Thorac Cardiovasc Surg (2003) 1.08
Downregulation of miR-153 contributes to epithelial-mesenchymal transition and tumor metastasis in human epithelial cancer. Carcinogenesis (2012) 1.08
The effect of sustained delivery of vascular endothelial growth factor on angiogenesis in tissue-engineered intestine. Biomaterials (2008) 1.07
Adipose stem cells originate from perivascular cells. Biol Cell (2011) 1.07
Osteocalcin protein sequences of Neanderthals and modern primates. Proc Natl Acad Sci U S A (2005) 1.07
Repairing critical-sized calvarial defects with BMSCs modified by a constitutively active form of hypoxia-inducible factor-1α and a phosphate cement scaffold. Biomaterials (2011) 1.06
The use of injectable sonication-induced silk hydrogel for VEGF(165) and BMP-2 delivery for elevation of the maxillary sinus floor. Biomaterials (2011) 1.05
Direct-puncture embolization of intraosseous arteriovenous malformation of jaws. J Oral Maxillofac Surg (2002) 1.04
Enhanced osteoporotic bone regeneration by strontium-substituted calcium silicate bioactive ceramics. Biomaterials (2013) 1.04
Apatite-coated silk fibroin scaffolds to healing mandibular border defects in canines. Bone (2009) 1.03
Diaphragmatic repair through fetal tissue engineering: a comparison between mesenchymal amniocyte- and myoblast-based constructs. J Pediatr Surg (2006) 1.03
Combination of bone tissue engineering and BMP-2 gene transfection promotes bone healing in osteoporotic rats. Cell Biol Int (2008) 1.02
Effect of GLP-2 on mucosal morphology and SGLT1 expression in tissue-engineered neointestine. Am J Physiol Gastrointest Liver Physiol (2003) 1.01
Formation of a mandibular condyle in vitro by tissue engineering. J Oral Maxillofac Surg (2003) 1.01
Vertical alveolar ridge augmentation with beta-tricalcium phosphate and autologous osteoblasts in canine mandible. Biomaterials (2009) 1.01
Engineering extracellular matrix through nanotechnology. J R Soc Interface (2010) 1.00
Non-invasive optical detection of cathepsin K-mediated fluorescence reveals osteoclast activity in vitro and in vivo. Bone (2008) 1.00
Blood vessel formation in the tissue-engineered bone with the constitutively active form of HIF-1α mediated BMSCs. Biomaterials (2011) 1.00
Cyclic tensile stretch modulates osteogenic differentiation of adipose-derived stem cells via the BMP-2 pathway. Arch Med Sci (2010) 1.00
The retention of extracellular matrix proteins and angiogenic and mitogenic cytokines in a decellularized porcine dermis. Biomaterials (2010) 1.00
Engineering ear constructs with a composite scaffold to maintain dimensions. Tissue Eng Part A (2011) 0.99
Suppression of salivary adenoid cystic carcinoma growth and metastasis by ErbB3 binding protein Ebp1 gene transfer. Int J Cancer (2007) 0.99
CCND1 as a predictive biomarker of neoadjuvant chemotherapy in patients with locally advanced head and neck squamous cell carcinoma. PLoS One (2011) 0.99
Tissue engineering and organ structure: a vascularized approach to liver and lung. Pediatr Res (2008) 0.98
Prospects for tooth regeneration. Periodontol 2000 (2006) 0.98
Toward regenerating a human thumb in situ. Tissue Eng Part A (2009) 0.97
Expression of stem cell factor and its receptor, c-kit, in human oral mesenchymal cells. Eur J Oral Sci (2006) 0.97
Regeneration of articular cartilage by adipose tissue derived mesenchymal stem cells: perspectives from stem cell biology and molecular medicine. J Cell Physiol (2013) 0.97
Common pediatric elbow fractures. Orthop Nurs (2011) 0.97
Sciatic nerve regeneration in rats by a promising electrospun collagen/poly(ε-caprolactone) nerve conduit with tailored degradation rate. BMC Neurosci (2011) 0.97
Effects of soluble cobalt and cobalt incorporated into calcium phosphate layers on osteoclast differentiation and activation. Biomaterials (2008) 0.96
Dynamic rotational seeding and cell culture system for vascular tube formation. Tissue Eng (2003) 0.96